Login
$MDLK
$0.00 +$0.00 (0.0%) Close

Consolidated balance sheets

In USD, except per-share amounts
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q4 FY2016
As of Dec 31, 2016
Q3 FY2016
As of Sep 30, 2016
Q2 FY2016
As of Jul 22, 2016
Q1 FY2016
As of Mar 31, 2016
Q4 FY2015
As of Dec 31, 2015
Q3 FY2015
As of Sep 30, 2015
ASSETS
Current Assets
Cash and bank balance
Accounts receivable
Contract assets including retainage, net
Prepaid expenses and other current assets, net
Amount due from a related company
Amount due from an associate
Amount due from immediate holding company
Loan receivable
Amount due from related companies
Total Current Assets
Equipment, net
Investment in an associate
Long term prepayment
Total Non-Current Assets
Accumulated Depreciation Equipment
Pre-Paid Rent
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities
Accounts payable
Accrued expenses and other payables
Contract liabilities
Tax liabilities
Amount due to related companies
Amount due to directors
Notes payable
Total Current Liabilities
TOTAL LIABILITIES
STOCKHOLDERS’ EQUITY
Preferred stock: Series A Convertible Preferred Shares, $0.001 par value, 10,000,000 shares authorized, shares issued and outstanding: 200,000 as of March 31, 2026 and December 31, 2025
Common stock, $0.001 par value, 6,000,000,000 shares authorized, shares issued and outstanding: 3,969,933,920 as of March 31, 2026 and December 31, 2025
Additional paid-in capital
Exchange reserve
Accumulated deficit
TOTAL STOCKHOLDERS’ EQUITY
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support